Genexine saw the highest growth of 99% in patent filings in January and 99% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Genexine‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Genexine has been focused on protecting inventions in United States(US) with two publications in Q1 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 50% grants. The United States(US), and Canada(CA) patent Office are among the top ten patent offices where Genexine is filings its patents. Among the top granted patent authorities, Genexine has 50% of its grants in United States(US) and 50% in Canada(CA).
Regeneron Pharmaceuticals and Amgen could be the strongest competitors for Genexine
Patents related to rare diseases lead Genexine's portfolio
Genexine has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q1 2024.
Cervical cancer related patents lead Genexine portfolio followed by lymphocytopenia, and viral infections
Genexine has highest number of patents in cervical cancer followed by lymphocytopenia, viral infections, hepatitis c, and hepatitis b. For cervical cancer, nearly 100% of patents were filed and 12% of patents were granted in Q1 2024.
For comprehensive analysis of Genexine's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
